| Kimberly Michelle Mcgill, MD | |
|
300 Medical Pavilion Dr, Raeford, NC 28376-0019 | |
| (910) 904-8035 | |
| (910) 615-9752 |
| Full Name | Kimberly Michelle Mcgill |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 300 Medical Pavilion Dr, Raeford, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285839803 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uwh Of The Carolinas Pllc | 0042448169 | 290 |
News Archive
European psychiatrists' survey findings suggest that over half of all patients with bipolar disorder on prescribed medication show compliance issues, with most unable to attribute their deteriorating condition to this behavior.
Differing illness course, rather than the illness itself, is the greatest determinant of the differential risk of suicide attempts between patients with bipolar disorder and those with major depressive disorder, study findings indicate.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views - religious practice, health and social inequalities, discrimination, and political engagement showed no links.
› Verified 1 days ago
| Entity Name | Uwh Of The Carolinas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639506470 PECOS PAC ID: 0042448169 Enrollment ID: O20140118000107 |
News Archive
European psychiatrists' survey findings suggest that over half of all patients with bipolar disorder on prescribed medication show compliance issues, with most unable to attribute their deteriorating condition to this behavior.
Differing illness course, rather than the illness itself, is the greatest determinant of the differential risk of suicide attempts between patients with bipolar disorder and those with major depressive disorder, study findings indicate.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views - religious practice, health and social inequalities, discrimination, and political engagement showed no links.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Michelle Mcgill, MD 300 Medical Pavilion Dr, Raeford, NC 28376-0019 Ph: (910) 904-8035 | Kimberly Michelle Mcgill, MD 300 Medical Pavilion Dr, Raeford, NC 28376-0019 Ph: (910) 904-8035 |
News Archive
European psychiatrists' survey findings suggest that over half of all patients with bipolar disorder on prescribed medication show compliance issues, with most unable to attribute their deteriorating condition to this behavior.
Differing illness course, rather than the illness itself, is the greatest determinant of the differential risk of suicide attempts between patients with bipolar disorder and those with major depressive disorder, study findings indicate.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views - religious practice, health and social inequalities, discrimination, and political engagement showed no links.
› Verified 1 days ago